Statistics for Viking Therapeutics (id:5255 VKTX)
Valuation metrics
Market cap
4.71B
Enterprise value
3.78B
Trailing P/E (ttm)
-46.43
Forward P/E
-27.98
PEG ratio
-27.98
Price/Sales (ttm)
Price/Book (mrq)
5.17
Enterprise Value/Revenue
Enterprise Value/EBITDA
-37.59
Overview
Shares outstanding
111.44M
Float
105.46M
Shares short
18.07M
% Held by insiders
5.00%
% Held by institutions
3.00%
Average volume (10 days)
4.56M
Average volume (90 days)
Price summary
52-Week low
17.23
52-Week high
99.41
52-Week change
54.70%
Beta
3.00
50-Day moving average
57.81
200-Day moving average
61.71
Dividends and splits
Forward annual dividend rate
Forward annual dividend yield
Trailing annual dividend rate
0.00%
Trailing annual dividend yield
0.00
5-Year annual dividend yield
Payout ratio
0.00
Dividend date
Ex-dividend date
Last split factor
2:1
Last split date
Financials
Fiscal yearFiscal year ends
December 31, 2023
Most recent quarter (mrq)
September 30, 2024
Profitability
Profit margin
0.00%
Operating margin
0.00%
Operational effectiveness
Return on assets
-12.68%
Return on equity
-15.50%
Income statement
Revenue (ttm)
0.00
Revenue per share (ttm)
0.00
Quarterly revenue growth (yoy)
Gross profit (ttm)
0.00
EBITDA
0.00
Net income to common (ttm)
-99,151,000.00
Diluted EPS (ttm)
3.00
Quarterly earnings growth (yoy)
Balance sheet
Total cash (mrq)
930.44M
Total cash per share (mrq)
8.35
Total debt (mrq)
1.24M
Total Debt/Equity (mrq)
3.00
Current ratio (mrq)
3.65K%
Book value per share (mrq)
8.18
Cash flow
Cash flow statement
-74,249,000.00
Levered free cash flow (LFCF)
-44,290,000.00